Carbidopa/levodopa GR: Phase III started

Intec began a double-blind, double-dummy, U.S. Phase III trial to compare oral AP-CDLD containing 50 mg carbidopa with 400 or 500 mg levodopa given twice or 3 times daily vs. Sinemet IR levodopa/carbi...